Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

BIONANO GENOMICS ($BNGO) Releases Q2 2026 Earnings

None

BIONANO GENOMICS ($BNGO) posted quarterly earnings results for Q2 2026 on Monday, August 10th. The company reported earnings of -$0.64 per share, beating estimates of -$0.70 by $0.06. The company also reported revenue of $8,170,000, beating estimates of $7,625,520 by $544,480.

You can see Quiver Quantitative's $BNGO stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

EARLY ACCESS
Receive BNGO Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

BIONANO GENOMICS Hedge Fund Activity

We have seen 13 institutional investors add shares of BIONANO GENOMICS stock to their portfolio, and 12 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

BIONANO GENOMICS Government Contracts

We have seen $43,124 of award payments to $BNGO over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles